Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19 Read more about Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-1912 views
Serological surveillance of healthcare workers to evaluate natural infection- and vaccine-derived immunity to SARS-CoV-2 during an outbreak in Dili, Timor-Leste Read more about Serological surveillance of healthcare workers to evaluate natural infection- and vaccine-derived immunity to SARS-CoV-2 during an outbreak in Dili, Timor-Leste17 views
The use of residual serum samples to perform serological surveillance of severe acute respiratory syndrome coronavirus 2 in Dili and regional areas of Timor-Leste Read more about The use of residual serum samples to perform serological surveillance of severe acute respiratory syndrome coronavirus 2 in Dili and regional areas of Timor-Leste19 views
Australian Vasculitis working group and Paediatric Active Enhanced Disease Surveillance (PAEDS) network. Lower risk of multi-system inflammatory syndrome in children (MIS-C) with the omicron variant Read more about Australian Vasculitis working group and Paediatric Active Enhanced Disease Surveillance (PAEDS) network. Lower risk of multi-system inflammatory syndrome in children (MIS-C) with the omicron variant13 views
Paediatric SARS-CoV-2 serosurvey 2022, Australia: Summary report Submitted by Anonymous on Wed, 02/11/2022 The Paediatric Active Enhanced Disease Surveillance (PAEDS) Network and the National Centre for Immunisation Research and Surveillance (NCIRS) conducted a study to estimate the seroprevalence of SARS-CoV-2 antibodies in children and adolescents aged 0–19 years until August 2022. The study findings suggest there have been high rates of infection in children and adolescents of all ages across Australia, including those whose parents had not suspected infection and in vaccinated children. Read more about Paediatric SARS-CoV-2 serosurvey 2022, Australia: Summary report181 views
Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2016-2018 Submitted by Anonymous on Fri, 24/06/2022 This summary report on vaccine preventable diseases (VPDs) in Australia brings together the three most important national sources of routinely collected data on VPDs – notifications, hospitalisations and deaths – for all age groups for the three-year period 1 January 2016 to 31 December 2018. This report, prepared by NCIRS, has been published as a supplement in the Communicable Diseases Intelligence journal. NCIRS has published six of these reports since 2000. Read more about Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2016-2018116 views
Seroprevalence of SARS-CoV-2-specific antibodies in Sydney, Australia following the first epidemic wave in 2020 Read more about Seroprevalence of SARS-CoV-2-specific antibodies in Sydney, Australia following the first epidemic wave in 202028 views
Active surveillance of acute pediatric hospitalisations demonstrates the impact of vaccination programs and informs vaccine policy in Canada and Australia Read more about Active surveillance of acute pediatric hospitalisations demonstrates the impact of vaccination programs and informs vaccine policy in Canada and Australia72 views
Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety Read more about Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety59 views
Surveillance of adverse events following immunisation in Australia annual report, 2018 Read more about Surveillance of adverse events following immunisation in Australia annual report, 201882 views
